Home
ImmunityBio IBRX paid Continental Strategy $60K for lobbying in Q1 2026
Trade details
- Type
- Lobbying report
- Amount
- $60,000
- Quarter
- Q1 2026
- Stock
- ImmunityBio IBRX
- Client
- Immunitybio
- Reported
- 26/04/18
Up 0.0% from last quarter
What else happened in ImmunityBio around then
Filed or reported within 30 days of the trade day · 03/01~04/30Immunitybio's other lobbying reports
- Immunitybio
LobbyingImmunityBio
LobbyingImmunityBio
IBRX
Under $5,000
Under $5,000
Reported 07/19
for Q2
- Immunitybio
LobbyingImmunityBio
LobbyingImmunityBio
IBRX
$60K
$60K
Reported 01/19
for Q4 2025